Keeping Medtech Real-World Evidence Real

article image

Meet Sandra Siami, the new head of NESTcc, the organization helping to drive and refine the use of real-world evidence by both regulators and industry, a trend accelerated by the COVID-19 pandemic and likely to remain when the crisis ends.

It is said that every crisis also creates opportunities. When it comes to COVID-19 and medtech, those opportunities appear largely to be taking the form of increased diagnostics applications, along with accelerating several process-based changes. Key among those is the increased use of telehealth services which has garnered much attention, but perhaps equally important is the development and growth of real-world data and evidence (RWE).


This article is restricted to subscribers only.

Sign in to continue reading.


We're here to help! Please contact us at: